| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2001;32:392.)
© 2001 American Heart Association, Inc.
Original Contributions |
Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe
Data From a Multicenter Multinational Hospital–Based Registry (The European Community Stroke Project)
From the Department of Neurological and Psychiatric Sciences (M.L., G.P., A.M.B., G.T., P.V., D.I.), University of Florence, Florence, Italy; the National Research Council of Italy (CNR-CSFET) (A.D.C.), Italian Longitudinal Study on Aging, Florence, Italy; Health Area 10 (S.S., M.C.B., G.L., A.G.), Florence, Italy; and the Department of Public Health Sciences (C.D.A.W.), The Guy’s, Kings College, and St Thomas’ Hospital Medical and Dental School, Guy’s Campus, London, England.
Background and Purpose—The role of atrial fibrillation (AF) as a determinant of stroke outcome is not well established. Studies focusing on this topic relied on relatively small samples of patients, scarcely representative of the older age groups. We aimed at evaluating clinical characteristics, care, and outcome of stroke associated with AF in a large European sample.
Methods—In a European Concerted Action involving 7 countries, 4462 patients hospitalized for first-in-a-lifetime stroke were evaluated for demographics, risk factors, clinical presentation, resource use, and 3-month survival, disability (Barthel Index), and handicap (Rankin scale).
Results—AF was present in 803 patients (18.0%). AF patients, compared with those without AF, were older, were more frequently female, and more often had experienced a previous myocardial infarction; they were less often diabetics, alcohol consumers, and smokers (all P<0.001). At 3 months, 32.8% of the AF patients were dead compared with 19.9% of the non-AF patients (P<0.001). With control for baseline variables, AF increased by almost 50% the probability of remaining disabled (multivariate odds ratio 1.43, 95% CI 1.13 to 1.80) or handicapped (multivariate odds ratio 1.51, 95% CI 1.13 to 2.02). Before stroke, only 8.4% of AF patients were on anticoagulants. The chance of being anticoagulated was reduced by 4% per year of increasing age. AF patients underwent CT scan and other diagnostic procedures less frequently and received less physiotherapy or occupational therapy.
Conclusions—Stroke associated with AF has a poor prognosis in terms of death and function. Prevention and care of stroke with AF is a major challenge for European health systems.
Key Words: atrial fibrillation • prognosis • stroke management • stroke outcome • stroke prevention
This article has been cited by other articles:
 |
|
 |
|
  S. Gupta, M. E. Faughnan, and A. M. Bayoumi Embolization for Pulmonary Arteriovenous Malformation in Hereditary Hemorrhagic Telangiectasia: A Decision Analysis Chest, September 1, 2009; 136(3): 849 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Bejot, D. B. Salem, G. V. Osseby, G. Couvreur, J. Durier, C. Marie, Y. Cottin, T. Moreau, and M. Giroud Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006 Neurology, January 27, 2009; 72(4): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Grad, H. Sievert, B. Nishri, G. W. Stone, B. T. Katzen, O. Yodfat, R. Higashida, D. Harris, A. K. Wakhloo, Y. Assaf, et al. A Novel Endovascular Device for Emboli Rerouting: Part I: Evaluation in a Swine Model Stroke, October 1, 2008; 39(10): 2860 - 2866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nieuwlaat, A. Capucci, G. Y.H. Lip, S. B. Olsson, M. H. Prins, F. H. Nieman, J. Lopez-Sendon, P. E. Vardas, E. Aliot, M. Santini, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur. Heart J., December 2, 2006; 27(24): 3018 - 3026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Niewada, M. Skowronska, D. Ryglewicz, B. Kaminski, A. Czlonkowska, and on behalf of the Polish National Stroke Prevention Acute Ischemic Stroke Care and Outcome in Centers Participating in the Polish National Stroke Prevention and Treatment Registry Stroke, July 1, 2006; 37(7): 1837 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L J Gray, N Sprigg, P M W Bath, P Sorensen, E Lindenstrom, G Boysen, P P De Deyn, P Friis, D Leys, R Marttila, et al. Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST) J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 327 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bushi, Y. Grad, S. Einav, O. Yodfat, B. Nishri, and D. Tanne Hemodynamic Evaluation of Embolic Trajectory in an Arterial Bifurcation: An In-Vitro Experimental Model Stroke, December 1, 2005; 36(12): 2696 - 2700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Voller In defence of current treatment options: where are we now? Eur. Heart J. Suppl., June 1, 2005; 7(suppl_E): E4 - E9. [Full Text] [PDF]
|
|
|
|
|
|
J. Emmerich, J.-Y. Le Heuzey, P. M.W. Bath, and S. J. Connolly Indication for antithrombotic therapy for atrial fibrillation: reconciling the guidelines with clinical practice Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C28 - C33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S.J. Miller, M. F. Drummond, L. K. Langkilde, J. J.V. McMurray, and M. Ogren Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C41 - C54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S.J. Miller, F. L. Andersson, and L. Kalra Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated? Stroke, February 1, 2005; 36(2): 360 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Thijs More bad news about atrial fibrillation Eur. Heart J., October 1, 2004; 25(19): 1670 - 1671. [Full Text] [PDF]
|
|
|
|
|
|
C. Steger, A. Pratter, M. Martinek-Bregel, M. Avanzini, A. Valentin, J. Slany, and C. Stollberger Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry Eur. Heart J., October 1, 2004; 25(19): 1734 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Hylek, A. S. Go, Y. Chang, N. G. Jensvold, L. E. Henault, J. V. Selby, and D. E. Singer Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation N. Engl. J. Med., September 11, 2003; 349(11): 1019 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vermes, J.-C. Tardif, M. G. Bourassa, N. Racine, S. Levesque, M. White, P. G. Guerra, and A. Ducharme Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials Circulation, June 17, 2003; 107(23): 2926 - 2931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Di Carlo, M. Lamassa, M. Baldereschi, G. Pracucci, A. M. Basile, C. D.A. Wolfe, M. Giroud, A. Rudd, A. Ghetti, and D. Inzitari Sex Differences in the Clinical Presentation, Resource Use, and 3-Month Outcome of Acute Stroke in Europe: Data From a Multicenter Multinational Hospital-Based Registry Stroke, May 1, 2003; 34(5): 1114 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart, S. Palacio, and L. A. Pearce Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy: Analysis of Randomized Clinical Trials Stroke, November 1, 2002; 33(11): 2722 - 2727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Dudley Importance of risk communication and decision making in cardiovascular conditions in older patients: a discussion paper Qual. Saf. Health Care, September 1, 2001; 10(90001): i19 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Sharma, A. Di Carlo, M. Lamassa, and D. Inzitari Re: Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe Stroke, September 1, 2001; 32(9): 2206 - 2206. [Full Text] [PDF]
|
|